All 3 shFbxo11 samples showed a striking decrease in NPM1, which is consistent with our observation in primary MDS CD34+ cells and further supports a model in which ubiquitylation by SCF-FBXO11 maintained NPM1 levels (Figure 6O). This evidence concerns the gene CD34 and myelodysplastic syndrome.